Skip to main content
Year archive

Vicore Pharma Holding — 2021 filings

All 36 regulatory filings released by Vicore Pharma Holding (VICO) in 2021, sourced directly from the official regulator.

36 Filings
2021 Period
2021 filings (36)
Filing Released Lang
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-01 English
Interim report July - September 2021
Interim / Quarterly Report Q3 2021
2021-11-04 English
Interim / Quarterly Report 2021
Interim / Quarterly Report Q3 2021
2021-11-04 Swedish
Vicores C21 minskar långsiktiga lungskador efter COVID-19 i ATTRACT fas 2 uppföljningsstudien
Earnings Release FY 2021
2021-11-02 Swedish
Vicore’s C21 reduces long-term lung injury after COVID-19 in the ATTRACT Phase 2 extension study
Earnings Release FY 2021
2021-11-02 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-26 Swedish
Interim report April - June 2021
Interim / Quarterly Report H1 2021
2021-08-26 English
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)
AGM Information
2021-05-11 English
Kommuniké från årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2021-05-11 Swedish
Delårsrapport januari - mars 2021
Interim / Quarterly Report Q1 2021
2021-05-05 Swedish
Interim report January - March 2021
Interim / Quarterly Report Q1 2021
2021-05-05 English
Vicore inleder samarbete med Alex Therapeutics för att utveckla en digital terapi för patienter med IPF
Regulatory Filings
2021-05-04 Swedish
Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF
Regulatory Filings
2021-05-04 English
Annual Report 2020
Annual Report FY 2020
2021-04-15 Swedish
Vicore Pharma publishes the Annual Report for 2020
Annual Report FY 2020
2021-04-15 English
Vicore Pharma offentliggör årsredovisning för 2020
Annual Report FY 2020
2021-04-15 Swedish
Kallelse till årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2021-04-08 Swedish
Notice of annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2021-04-08 English
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2021-03-31 Swedish
Increase of number of shares and votes in Vicore Pharma
Declaration of Voting Results & Voting Rights Announcements
2021-03-31 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-03-23 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-03-18 English
Vicore Pharma’s läkemedelskandidat C21 vidgar perifera blodkärl vid fibrotisk sjukdom
Regulatory Filings
2021-03-11 Swedish
Vicore Pharma’s drug candidate C21 dilates peripheral resistance vessels in fibrotic disease
Earnings Release FY 2021
2021-03-11 English
Kommuniké från extra bolagsstämma i Vicore Pharma Holding AB (publ)
Share Issue/Capital Change
2021-03-05 Swedish
Press release from the extraordinary general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2021-03-05 English
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2021-02-26 English
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2021-02-26 Swedish
Bokslutskommuniké 2020
Interim / Quarterly Report FY 2020
2021-02-26 Swedish
Year-end report 2020
Interim / Quarterly Report FY 2020
2021-02-26 English
Kallelse till extra bolagsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2021-02-10 Swedish
Notice of extraordinary general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2021-02-10 English
Vicore Pharma har genomfört en riktad nyemission om 336 miljoner kronor
Share Issue/Capital Change
2021-02-10 Swedish
Vicore Pharma has completed a directed share issue of SEK 336 million
Capital/Financing Update
2021-02-10 English
Vicore Pharma avser att genomföra en riktad nyemission
Capital/Financing Update
2021-02-09 Swedish
Vicore Pharma intends to carry out a directed share issue
Capital/Financing Update
2021-02-09 English